Seems almost too good to be true, there might be a catch.
https://fee.org/articles/could-mark-cuban-s-plan-to-disrupt-big-pharma-actually-work/“A 30-count of imatinib, which is used to treat leukemia and other cancers, goes for as low as $17.10 at Cuban's pharmacy compared with $2,502.60 at other pharmacies,” reported NPR’s Joe Hernandez